HIND — Vyome Holdings Share News
0.000.00%
Last trade - 00:00- $12.56m
- $5.94m
- $0.32m
Brief: Reshape Lifesciences Announces Pricing Of $2.5 Million Registered Direct Offering And Concurrent Private Placement Priced At-The-Market
Brief: Reshape Lifesciences Inc Says On April 7, Board Determined Co's Financial Statements For Year Ended Dec 31, 2021, Were Materially Misstated
ReShape Lifesciences up on patent for weight loss device
Brief: Reshape Lifesciences Receives Notice Of Allowance For US Patent Related To Obalon Balloon System
Brief: Reshape Lifesciences To Delay Year Ended December 31, 2022 Earnings Release And Conference Call
ReShape Lifesciences Inc expected to post a loss of $10.00 a share - Earnings Preview
ReShape Lifesciences Inc expected to post a loss of $10.00 a share - Earnings Preview
Brief: Reshape Lifesciences Announces Formation Of International Scientific Advisory Board
Brief: Matthew Nachtrab Reports 27.7% Stake In Reshape Lifesciences As Of Feb 6 - SEC Filing
Brief: ReShape Lifesciences Inc Says On Feb 6, 2023, Co Entered Into An Underwriting Agreement With Maxim Group LLC
U.S. STOCKS ON THE MOVE-Fat Brands, Spotify, Uber Tech
U.S. STOCKS ON THE MOVE-Apple, PayPal, Pinterest
Brief: ReShape Announces Pricing Of Upsized $10.2 Mln Underwritten Public Offering
ReShape Lifesciences plunges on deep-discounted equity offering
U.S. STOCKS ON THE MOVE-Catalent, Tesla, Newmont
Brief: ReShape Lifesciences Files For Offering Of Up To 1.1 Mln Units At $7.67 Per Unit
Brief: ReShape Lifesciences Announces 1-For-50 Reverse Stock Split
ReShape Lifesciences Inc reports results for the quarter ended in September - Earnings Summary
ReShape Lifesciences Inc expected to post a loss of 35 cents a share - Earnings Preview